The trademark RESETA was filed by MEDISILK S.P.A., a corporation established under the laws of the Italian Republic (the "Applicant"). The application was published for oppositions on November 4, 2021, and received one opposition filed on February 3, 2022 by Novartis AG on Likelihood of confusion. the opponent was represented by Nordemann Czychowski & Partner Rechtsanwältinnen und Rechtsanwälte mbB and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued February 3, 2022
The application was filed in Italian, and Italian was also language of all opposition proceedings (English was selected as the second language).